KENILWORTH and WHITEHOUSE STATION, N.J., Aug. 28 -- Schering-Plough/Merck Pharmaceuticals (SPM) today announced that the New Drug Application filing for loratadine/montelukast has been accepted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback